Mangoceuticals, Inc. Common Stock (MGRX) Stock Price
MGRXStock
$0.29−88.22%52W
Market Cap$6.44M
P/E—
PEG Ratio—
Div yield—
Beta2.18
MGRX Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-35.19%
Price vs S&P 500 (4W)-34.32%
VGM Score16.91
Industry Peers — Health Services(17)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
MGRXMangoceuticals, Inc. Common Stock | D | F | F | — | -38.9% | -4761.2% | -106.1% | $0.29 |
| DVADaVita Inc. | B | C | B | 16.0x | 6.5% | 15.1% | 181.2% | $187.31 |
| FMSFresenius Medical Care AG | A | D | C | 10.7x | -0.5% | 9.4% | 7.2% | $22.17 |
| SHCSotera Health Company Common Stock | D | B | C | 65.5x | 8.2% | 32.6% | 26.8% | $17.89 |
| PGNYProgyny, Inc. Common Stock | C | B | C | 35.2x | 5.5% | 8.6% | 16.0% | $26.86 |
| AGLagilon health, inc. | B | B | B | — | 0.3% | -5.2% | -110.3% | $85.12 |
| MCTACharming Medical Limited Class A Ordinary Shares | F | F | A | 371.6x | — | 15.4% | — | $29.36 |
| VMDViemed Healthcare, Inc. Common Shares | B | C | C | 24.2x | 25.2% | 7.5% | 10.3% | $9.48 |
| PARKPark Dental Partners, Inc. Common Stock | B | F | C | 17.9x | — | -2.8% | -18.3% | $18.95 |
| CCELCryo-Cell International Inc. | C | D | B | 69.5x | -2.0% | 0.6% | 38.2% | $4.42 |
| BRTXBioRestorative Therapies, Inc. Common Stock (NV) | — | D | F | — | -8.5% | -3975.0% | -423.8% | $1.54 |
About Mangoceuticals, Inc. Common Stock
Mangoceuticals Inc operates a men's health telemedicine platform that connects patients with licensed providers for remote consultations and prescription services. The company leverages an integrated pharmacy network to fulfill and distribute medications, including its proprietary erectile dysfunction products. This vertically integrated model combines telehealth services with direct-to-consumer pharmacy fulfillment.